Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Thursday, November 27, 2014
Subscribe to:
Post Comments (Atom)
1 comment:
A few thoughts:
**Chemicals are recipes are SOLD for compounding but not warrantied for this use
**Boards need to to acknowledge financial incentives and conflicts of interest for recommending substitution of compounded drugs at individual and population levels under the guise of pharmacy professionalism (steering patients to compounds in lieu of regulated finished products to make more money)
**While boards are exceptionally well qualified and suited to regulate the licensing and professional practice of pharmacists and doctors, they are not well suited to regulating the safety, effectiveness and security of drug supplies
**There are no surveillance procedures for safety, quality, adverse event reporting and counterfeiting/bioterrorism chemical security for most states
**Pharmaceutical Care Models are useful at state levels for determining if and when a patient cannot be treated with an FDA-approved product, which carry product liability insurance, and what disclosures should be made regarding financial interests surrounding recommendations
**Having the often-claimed "right" to compound medications does not mean you should
**Compounded drugs may be compulsory for patients in certain settings (they are used based on contracts with health clinics, nursing homes) are a breach of professionalism and unethical if patients or their caregivers are not given an option to chose an FDA-approved, GMP-produced formulation
Post a Comment